Suraksha Diagnostic IPO subscription started on Friday, November 29, 2024 and will close on December 3, 2024 as per the schedule. The price band is set at ₹420 to ₹441 per share with a face value of ₹10.
Suraksha Diagnostic IPO Subscription Status
Suraksha Diagnostic IPO Subscribed over 0.11x on its first day till 5.00 PM on 29th November.
- Suraksha Diagnostic IPO subscription QIB investors portion is 0.00 times, while NII subscribed 0.04 times and RII investors subscribed 0.20 times.
- The company has received bids for 14,79,782 shares against 1,34,32,533 shares on offer on the first day of subscription.
- Suraksha Diagnostic IPO Subscribed over 0.11x on its day 1.
About Suraksha Diagnostic IPO
Suraksha Diagnostic was incorporated on 15 March 2005 and offers services like Medical testing, diagnostic solutions, and medical consultation. It is headquartered in East India and caters end-to-end solutions of pathology and radiology testing to its consumers through its functional network. Over time, it has collected various awards for identifying the brand’s awareness and focus in business. It has a good portfolio of over 2,300 tests including 788 pathology tests like basic biochemistry and haematology. 647 tests including advanced biochemistry, histopathology, and molecular pathology. In FY 2022 and 2024, the compounded annual growth rate(CAGR) of 20.87% in revenue and net income for FY 2024 was 23.13 crore. Furthermore, The leading diagnostic network with a strong presence in eastern India, outstanding profitability, and consistency in financial performance is a strength of this company. Due to its expertise have 1,522 permanent staff in the company.
Suraksha Diagnostic Company Financial Report
The company reported revenue of ₹218.71 crores in 2024 against ₹190.13 crore in 2023. The company reported Profit of ₹23.13 crores in 2024 against Profit of ₹6.07 crores in 2023.
Suraksha Diagnostic IPO GMP:
Suraksha Diagnostic IPO GMP was ₹0 as of Friday, November 29. That indicates the IPO is trading at ₹441 with ₹0 premium in the grey market against the issue price of ₹441.
